No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
MORF Morphic
- 30.800
- +3.040+10.95%
Close May 24 16:00 ET
- 30.730
- -0.070-0.23%
Post 18:09 ET
1.54BMarket Cap-8555P/E (TTM)
31.000High27.470Low823.81KVolume28.010Open27.760Pre Close24.51MTurnover2.44%Turnover RatioLossP/E (Static)50.09MShares63.08352wk High2.33P/B1.04BFloat Cap19.34552wk Low--Dividend TTM33.74MShs Float93.000Historical High--Div YieldTTM12.72%Amplitude9.900Historical Low29.755Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Morphic Demonstrates Novel Real-Time Visualization of Small Molecule Α4β7 Inhibition of Gut-Trafficking Cells
Supporting Materials: Impact of Potent and Selective Small Molecule Inhibitor Comparable to Monoclona... Impact of Potent and Selective Small Molecule Inhibitor Comparable to Monoclona...-α4
Morphic Ethical Funds Continues Share Buy-Back
Morphic Fund's Buyback Plan Wins Strong Approval
Morphic Fund Announces Upcoming Dividend
Morphic Fund Navigates Ethical Investing Amid Market Volatility
Morphic to Participate in RBC Capital Markets Global Healthcare Conference
WALTHAM, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chron
Comments
Insider buying paints a hopeful picture for Morphic Holding's future despite losses. High ownership by insiders hints at alignment with shareholders' interests, possibly seeing the current stock price as low.
Bullish Morphic Holding Insiders Loaded Up On US$47.3m Of Stock
1 | Below is a look at the top insider trades with the biggest value in the past week.
On May 03, 2023, Timothy A Springer, director of $Morphic(MORF.US$, acquired a total of 1,050,000 shares at an average price of $45.00. Acquiring these shares, it costs around $47.25 million.
On the same day, Morphic Holding announced the pr...
On May 03, 2023, Timothy A Springer, director of $Morphic(MORF.US$, acquired a total of 1,050,000 shares at an average price of $45.00. Acquiring these shares, it costs around $47.25 million.
On the same day, Morphic Holding announced the pr...
8
1
Implied volatility is a measure of the market's expectation of the potential price movements of the stock in the future. Here are the stocks with the most notable Implied volatility today."
Here are the notable stocks with the highest and lowest implied volatility.
The $Seres Therapeutics(MCRB.US$, $First Republic Bank(FRC.US$, and $Morphic(MORF.US$has the highest implied volatility of all stocks with a mark...
Here are the notable stocks with the highest and lowest implied volatility.
The $Seres Therapeutics(MCRB.US$, $First Republic Bank(FRC.US$, and $Morphic(MORF.US$has the highest implied volatility of all stocks with a mark...
10
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg